Literature DB >> 28728641

Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders.

Susan M Paddock1, Kimberly A Hepner1, Teresa Hudson2,3, Songthip Ounpraseuth2,3, Amy M Schrader2,3, Greer Sullivan4, Katherine E Watkins1.   

Abstract

OBJECTIVE: Substance use disorders (SUDs) are associated with elevated rates of mortality. Little is known about whether receiving appropriate care is associated with lower mortality for patients with SUDs. This study examined the association between the receipt of care for SUDs and subsequent 12- and 24-month mortality.
METHOD: This was a retrospective cohort study of veterans who received care for SUDs paid for by the Veterans Health Administration during October 2006- September 2007 (n = 339,966). Logistic regressions were used to examine the association between quality indicators measuring receipt of care and mortality while controlling for patient characteristics and facility service area.
RESULTS: There were four quality indicators: SUD treatment initiation, SUD treatment engagement, SUD-related psychosocial treatment, and SUD-related psychotherapy. Outcomes measured were mortality 12 and 24 months after the end of the observation period, through September 2009. Receipt of indicated care ranged from 26.5% to 58.6%, and 12- and 24-month mortality rates were 3% and 6%, respectively. Adjusted odds ratios [95% CI] of 12-month mortality by indicator were: initiation, 0.86 [0.79, 0.93]; engagement, 0.65 [0.58, 0.74]; psychosocial treatment, 0.88 [0.84, 0.92]; and psychotherapy, 0.84 [0.79, 0.89]. For the 24-month mortality outcome, adjusted odds ratios were: initiation, 0.88 [0.84, 0.93]; engagement, 0.78 [0.71, 0.85]; psychosocial treatment, 0.91 [0.88, 0.94]; and psychotherapy, 0.87 [0.83, 0.91]. Results were similar when controlling for facility service area.
CONCLUSIONS: Receiving appropriate care is associated with lower mortality for patients with SUDs. Significant overall and within-facility service area associations of quality indicators and mortality support their use in encouraging providers to deliver the indicated care. These indicators should be prioritized above others lacking comparably strong process-outcome associations.

Entities:  

Mesh:

Year:  2017        PMID: 28728641      PMCID: PMC5551663          DOI: 10.15288/jsad.2017.78.588

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  34 in total

1.  Care for veterans with mental and substance use disorders: good performance, but room to improve on many measures.

Authors:  Katherine E Watkins; Harold Alan Pincus; Susan Paddock; Brad Smith; Abigail Woodroffe; Carrie Farmer; Melony E Sorbero; Marcela Horvitz-Lennon; Thomas Mannle; Kimberly A Hepner; Jacob Solomon; Cathy Call
Journal:  Health Aff (Millwood)       Date:  2011-10-19       Impact factor: 6.301

2.  Predictive validity of a quality measure for intensive substance use disorder treatment.

Authors:  Eric M Schmidt; Shalini Gupta; Thomas Bowe; Laura S Ellerbe; Tyler E Phelps; John W Finney; Steven M Asch; Keith Humphreys; Jodie Trafton; Megan Vanneman; Alex H S Harris
Journal:  Subst Abus       Date:  2016-07-19       Impact factor: 3.716

3.  Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness.

Authors:  Alex H S Harris; Keith Humphreys; John W Finney
Journal:  J Subst Abuse Treat       Date:  2007-04-02

4.  Are Washington Circle performance measures associated with decreased criminal activity following treatment?

Authors:  Deborah W Garnick; Constance M Horgan; Margaret T Lee; Lee Panas; Grant A Ritter; Steve Davis; Tracy Leeper; Rebecca Moore; Mark Reynolds
Journal:  J Subst Abuse Treat       Date:  2007-05-23

5.  Assessing the sensitivity of regression results to unmeasured confounders in observational studies.

Authors:  D Y Lin; B M Psaty; R A Kronmal
Journal:  Biometrics       Date:  1998-09       Impact factor: 2.571

6.  Surviving drug addiction: the effect of treatment and abstinence on mortality.

Authors:  Christy K Scott; Michael L Dennis; Alexandre Laudet; Rodney R Funk; Ronald S Simeone
Journal:  Am J Public Health       Date:  2011-02-17       Impact factor: 9.308

7.  Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.

Authors:  Elizabeth M Oliva; Alex H S Harris; Jodie A Trafton; Adam J Gordon
Journal:  Drug Alcohol Depend       Date:  2011-11-23       Impact factor: 4.492

8.  Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association.

Authors: 
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112

9.  Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy.

Authors:  John W Finney; Keith Humphreys; Daniel R Kivlahan; Alex H S Harris
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

10.  Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.

Authors:  Katherine E Watkins; Susan M Paddock; Teresa J Hudson; Songthip Ounpraseuth; Amy M Schrader; Kimberly A Hepner; Greer Sullivan
Journal:  J Subst Abuse Treat       Date:  2016-06-07
View more
  13 in total

1.  Assessing the postdeployment quality of treatment for substance use disorders among Army enlisted soldiers in the Military Health System.

Authors:  Rachel Sayko Adams; Deborah W Garnick; Alex H S Harris; Elizabeth L Merrick; Keith Hofmann; Wendy Funk; Thomas V Williams; Mary Jo Larson
Journal:  J Subst Abuse Treat       Date:  2020-05-07

2.  Association between process measures and mortality in individuals with opioid use disorders.

Authors:  Katherine E Watkins; Susan M Paddock; Teresa J Hudson; Songthip Ounpraseuth; Amy M Schrader; Kimberly A Hepner; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2017-06-27       Impact factor: 4.492

3.  Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial.

Authors:  Katherine E Watkins; Allison J Ober; Karen Lamp; Mimi Lind; Claude Setodji; Karen Chan Osilla; Sarah B Hunter; Colleen M McCullough; Kirsten Becker; Praise O Iyiewuare; Allison Diamant; Keith Heinzerling; Harold Alan Pincus
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

4.  The importance of identification when measuring performance in addiction treatment.

Authors:  Deborah Garnick; Constance Horgan; Tami L Mark; Margaret Lee; Andrea Acevedo; Sarah Neager; Peggy O'Brien; Ali Hashmi; Bill Marder; Kay Miller
Journal:  Subst Abus       Date:  2019-03-26       Impact factor: 3.716

5.  Rates and Impact of Adherence to Recommended Care for Unhealthy Alcohol Use.

Authors:  Kimberly A Hepner; Susan M Paddock; Katherine E Watkins; Katherine J Hoggatt; Lisa V Rubenstein; Andy Bogart; Praise O Iyiewuare; Susan C Rosenbluth; Harold Alan Pincus
Journal:  J Gen Intern Med       Date:  2018-11-27       Impact factor: 5.128

6.  Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.

Authors:  Andrea H Kline-Simon; Scott P Stumbo; Cynthia I Campbell; Ingrid A Binswanger; Constance Weisner; Irina V Haller; Rulin C Hechter; Brian K Ahmedani; Gwen T Lapham; Amy M Loree; Stacy A Sterling; Bobbi Jo H Yarborough
Journal:  Subst Abus       Date:  2019-01-31       Impact factor: 3.716

7.  Effects of motivational interviewing fidelity on substance use treatment engagement in primary care.

Authors:  Karen Chan Osilla; Katherine E Watkins; Elizabeth J D'Amico; Colleen M McCullough; Allison J Ober
Journal:  J Subst Abuse Treat       Date:  2018-01-31

Review 8.  Developing an opioid use disorder treatment cascade: A review of quality measures.

Authors:  Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Harold A Pincus; Kimberly A Johnson; Aimee N Campbell; Remien H Remien; Stephen Crystal; Peter D Friedmann; Frances R Levin; Mark Olfson
Journal:  J Subst Abuse Treat       Date:  2018-06-02

9.  Effectiveness of value-based purchasing for substance use treatment engagement and retention.

Authors:  Sharon Reif; Maureen T Stewart; Maria E Torres; Margot T Davis; Beth Mohr Dana; Grant A Ritter
Journal:  J Subst Abuse Treat       Date:  2020-12-03

10.  Predictors of timely opioid agonist treatment initiation among veterans with and without HIV.

Authors:  Jessica J Wyse; Jonathan L Robbins; Kathleen A McGinnis; E Jennifer Edelman; Adam J Gordon; Ajay Manhapra; David A Fiellin; Brent A Moore; P Todd Korthuis; Julie R Gaither; Kirsha Gordon; Melissa Skanderson; Declan T Barry; Stephen Crystal; Amy Justice; Kevin L Kraemer
Journal:  Drug Alcohol Depend       Date:  2019-03-09       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.